Use of proton pump inhibitors are associated with higher mortality in hospitalized patients with COV...
Use of proton pump inhibitors are associated with higher mortality in hospitalized patients with COVID-19
About this item
Full title
Author / Creator
Wu, Shengyong , Jin, Zhichao , Peng, Chi , Li, Dongdong , Cheng, Yi , Zhu, Ronghui , He, Jia and Wu, Cheng
Publisher
Scotland: Edinburgh University Global Health Society
Journal title
Language
English
Formats
Publication information
Publisher
Scotland: Edinburgh University Global Health Society
Subjects
More information
Scope and Contents
Contents
The adverse effects of proton pump inhibitors (PPIs) on pneumonia have been well reported. However, the relationship between the use of PPIs and the adverse outcomes of coronavirus disease 2019 (COVID-19) is currently inconclusive. In this study, we aimed to explore the relationship between the use of PPIs and the in-hospital mortality among patien...
Alternative Titles
Full title
Use of proton pump inhibitors are associated with higher mortality in hospitalized patients with COVID-19
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8849264
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8849264
Other Identifiers
ISSN
2047-2978
E-ISSN
2047-2986
DOI
10.7189/jogh.12.05005
